Molecular Designs secures first FDA clearance for SimplicityDx Panel FluA/FluB/RSV assay

Molecular Designs, a physician-founded developer and manufacturer of molecular infectious disease assays, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K262789) for its SimplicityDx…

Continue ReadingMolecular Designs secures first FDA clearance for SimplicityDx Panel FluA/FluB/RSV assay

Study finds earlier endometrial cancer diagnoses among Native American and Hispanic women

While incidence rates for some cancers have declined among women, endometrial cancer, the most common type of uterine cancer, has increased substantially over the past two decades, with particularly concerning…

Continue ReadingStudy finds earlier endometrial cancer diagnoses among Native American and Hispanic women

Researchers discover bacterial molecule that rapidly repairs intestinal damage

Scientists at Rutgers Health have discovered a molecule produced by "good" gut bacteria that rapidly heals the intestinal lining, protecting against severe inflammatory diseases and triggering increased production of a…

Continue ReadingResearchers discover bacterial molecule that rapidly repairs intestinal damage

New hybrid approach intensifies treatment for liver tumor metastases

Combining intraarterial and intravenous administration of peptide receptor radionuclide therapy (PRRT) can selectively intensify treatment for liver-dominant metastatic neuroendocrine tumors (NETs) while still effectively delivering treatment throughout the whole body.

Continue ReadingNew hybrid approach intensifies treatment for liver tumor metastases